Medtronic OmniaSecure™ defibrillation lead is the first lead of its kind to receive FDA approval for conduction system pacing

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, received U.S. Food and Drug Administration (FDA) ...

Medtronic wins CE mark for OmniaSecure defibrillation lead

The device maker designed the lead to have the safety benefits of small-diameter devices without sacrificing durability.

Medtronic’s OmniaSecure defibrillation lead earns expanded FDA indication

The OmniaSecure lead gained the first U.S. approval for placement in the heart’s left bundle branch area, to help activate ...
Medical Device and Diagnostic Industry (MD+DI)

Medtronic’s Tiny Defibrillation Lead Packs a Big Punch

Medtronic snagged FDA approval for an expanded indication for its OmniaSecure defibrillation lead. Check out why this tiny ...
MassDevice

Biotronik study backs 2-lead defibrillation system

Results from the multi-center CRT-NEXT study demonstrated that CRT-DX is as safe and effective as conventional three-lead CRT ...
FierceBiotech

FDA approves Medtronic defibrillator that automatically adjusts pacing

The FDA approved Medtronic’s defibrillator that tailors cardiac resynchronization therapy (CRT) to each patient by using an algorithm to adjust pacing. With its ability to confirm if pulses are ...
MedPage Today

Leadless Pacing Wirelessly Linked to Subcutaneous Defibrillator Hits Targets for ATP

BOSTON -- A leadless pacemaker reliably communicated with a subcutaneous implantable cardioverter-defibrillator (S-ICD) to deliver anti-tachycardia (ATP) and bradycardia pacing, the MODULAR ATP study ...
Morningstar

Medtronic OmniaSecure™ defibrillation lead is the first lead of its kind to receive FDA approval for conduction system pacing

Built for high reliability, world's only lumenless defibrillation lead approved for placement in the left bundle branch area GALWAY, Ireland, March 23, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), ...